Karen E Peterson insider trades: Entellus Medical (ENTL) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Karen reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 9, 2017 | ENTL | ↓ Sell | 650 | $20.17 | $13K | Direct | Oct 11, 2017 (2d) |
| Jan 13, 2017 | ENTL | ↓ Sell | 10,000 | $20.13 | $201K | Direct | Jan 18, 2017 (5d) |
| Jan 10, 2017 | ENTL | ↓ Sell | 9,840 | $19.11 | $188K | Direct | Jan 10, 2017 (0d) |
| Jan 4, 2017 | ENTL | ↓ Sell | 10,160 | $18.74 | $190K | Direct | Jan 5, 2017 (1d) |
| Mar 3, 2016 | ENTL | ↓ Sell | 5,000 | $16.00 | $80K | Direct | Mar 3, 2016 (0d) |
| Feb 11, 2016 | ENTL | ↓ Sell | 5,000 | $16.00 | $80K | Direct | Feb 11, 2016 (0d) |
| Feb 4, 2016 | ENTL | ↓ Sell | 10,000 | $17.00 | $170K | Direct | Feb 4, 2016 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Karen E Peterson's insider trades
Karen E Peterson is VP, Regulatory and Quality at Entellus Medical (ENTL). Since Feb 4, 2016, Karen has reported no open-market purchases and 7 sales worth $923K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ENTL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.